Renal effects of captopril, indomethacin and nifedipine in nephrotic patients after an oral protein load

Nephrology Dialysis Transplantation

Volumn 11, Issue 4, 1996, Pages 628-634

  Garini, G ^a   Mazzi, A ^a   Buzio, C ^a   Mutti, A ^a   Allegri, L ^a   Savazzi, G ^a   Borghetti, A ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

Angiotensin converting enzyme inhibitors; Calcium channel blockers; Glomerular; Haemodynamics; Nephrotic syndrome; Non steroidal anti inflammatory drugs; Proteinuria

Indexed keywords

4 AMINOHIPPURIC ACID; ALBUMIN; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOGLOBULIN G; INDOMETACIN; IOTALAMIC ACID; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY PLASMA FLOW; MALE; MEAN ARTERIAL PRESSURE; NEPHROTIC SYNDROME; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN DIET; PROTEIN INTAKE; PROTEIN URINE LEVEL; PROTEINURIA; URINARY EXCRETION;

EID: 0029913911     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.ndt.a027351     Document Type: Article

References (39)

1. Kaysen GA, Gambertoglio J, Jimenez I, Jones H, Hutchison FN. Effect of dietary protein intake on albumin homeostasis in nephrotic patients. Kidney Int 1986; 29: 572-577
2. Mansy H, Goodship TH, Tapson JS et al. Effect of a high protein diet in patients with the nephrotic syndrome. Clin Sci 1989; 77(4): 445-451
3. Mizuiri S, Hayashi I, Ozawa T, Hirata K, Takano M, Sasaki Y. Effects of an oral protein load on glomerular filtration rate in healthy controls and nephrotic patients. Nephron 1988; 48: 101-106
4. Brenner BM, Meyer TW, Hostetter TH. Dietary protein intake and the progressive nature of kidney disease. N Engl J Med 1985; 307: 652-659
5. Hutchison FN, Schambelan M, Kaysen GA. Modulation of albuminuria by dietary protein and converting enzyme inhibition. Am J Physiol 1987; 253: F719-F725
6. Donker AJM, Brentjens JRH, van der Hem GK, Arisz L. Treatment of the nephrotic syndrome with indomethacin. Nephron 1978; 22: 374-381
7. Zucchelli P, Zuccalà A, Borghi M et al. Long-term comparison between captopril and nifedipine in the progression of renal insufficiency. Kidney Int 1992; 42: 452-458
8. Zusman RM. Effects of converting-enzyme inhibitors on the renin-angiotensin-aldosterone, bradykinin, and arachidonic acid-prostaglandin systems: correlation of chemical structure and biologicactivity. Am J Kidney Dis 1987; 10 [Suppl. 1]: 13-23
9. Dunn MJ, Zambraski EJ. Renal effects of drugs that inhibit prostaglandin synthesis. Kidney Int 1980; 18: 609-622
10. Buzio C, Mutti A, Capani F et al. Circadian rhythm of proteinuria: effects of an evening meat meal. Nephrol Dial Transplant 1989; 4: 266-270
11. Montagna G, Buzio C, Calderini C, Quaretti P, Migone L. Relationship of proteinuria and albuminuria to posture and to urine collection period. Nephron 1983; 35: 143-144
12. Maroni BJ, Steinman TI, Mitch WE. A method for estimating nitrogen intake of patients with chronic renal failure. Kidney Int 1985; 27. 58-65
13. Prueksaritanont T, Chen M, Chiou WL. Simple and micro high-performance liquid chromatographic method for simultaneous determination of p-aminohippuric acid and iothalamate in biological fluids. J Chromatogr 1984; 306: 89-97
14. Buzio C, Mutti A, Perazzoli F et al. Protein-induced changes in kidney function depend on the time of administration but not on the dietry source. Nephron 1990; 56: 234-240
15. Shemesh O, Deen WM, Brenner BM, McNeely E, Myers BD. Effect of colloid volume expansion on glomerular barrier size-selectivity in humans. Kidney Int 1986; 29: 916-923
16. Rosenberg ME, Swanson JE, Thomas BL, Hostetter TH. Glomerular and hormonal responses to dietary protein intake in human renal disease. Am J Physiol 1987; 253: F1083-F1090
17. Hirschberg R, Kopple JD. Response of insulin-like growth factor I and renal hemodynamics to a high- and low-protein diet in the rat. J Am Soc Nephrol 1991; 1: 1034-1037
18. Jaffa A, Vio CP, Silva RH, Vavrek RJ, Stewart JM, Rust PF. Evidence for renal kinins as mediators of amino acid-induced hyperperfusion and hyperfiltration in the rat. J Clin Invest 1992; 89: 1460-1468
19. Brenner BM, Hostetter TH, Humes HD. Molecular basis of proteinuria of glomerular origin. N Engl J Med 1978; 298: 826-833
20. Deen WM, Bridges CR, Brenner BM, and Myers BD. Heteroporous model of glomerular size-selectivity: application to normal and nephrotic humans. Am J Physiol 1985; 249. F374-F389
21. Hostetter TH, Rosenberg ME. Hemodynamic effects on glomerular permselectivity. Am J Nephrol 1990; 10 [Suppl. 1]: 24-27
22. Slomowitz LA, Hirschberg R, Kopple JD. Captopril augments the renal response to an amino acid infusion in diabetic adult. Am J Physiol 1988; 255: F755-F762
23. Woods LL. Mechanism of renal vasodilation after protein feeding: role of the renin-ansiotensin system. Am J Physiol 1993, 264: R601-R609
24. Gansevoort RT, de Zeeuw D, de Jong PE. Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system? Kidney Int 1994; 45: 861-867
25. Yoshioka T, Mitirai T, Kon V, Deen WM, Rennke HG, Ichikawa I. Role for angiotensin II in an overt functional proteinuria. Kidney Int 1986; 30. 538-545
26. Remuzzi A, Puntorieri S, Battaglia C, Bertani T, Remuzzi G. Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat J Clin Invest 1990, 85: 541-549
27. De Zeeuw D, Heeg JE, de Jong PE. The antiproteinuric effect of angiotensin converting enzyme inhibitors in human renal disease. In: Andreucci VE, Fine LG, ed. International Yearbook of Nephrology. Springer Verlag, London, 1992: 95-113
28. Loutzenhiser R, Epstein M. Effects of calcium antagonists on renal hemodynamics. Am J Physiol 1985; 249: F619-F629
29. Bonventre JV. Calcium and the renal mesangial cell. In: Epstein M. Loutzenhiser R. ed. Calcium Antagonist and the Kidney. Hanley and Belfus, Philadelphia, 1990: 87-105
30. Churchill PC. Calcium, calcium antagonists, and renin secretion. In: Epstein M, Loutzenhiser R. ed. Calcium Antagonist and the Kidney. Hanley and Belfus, Philadelphia, 1990; 127-154
31. Taguma Y, Kitamoto Y, Futaki G et al. Effect of captopril on heavy proteinuria in azotemic diabetes. N Engl J Med 1985; 313: 1617-1620.
32. Arisz L, Donker AJM, Brentjens JRH, van der Hern GK. The effect of indomethacin on proteinuria and kidney function in the nephrotic syndrome. Acta Med Scand 1976; 199: 121-125
33. Schnermann JJ, Biggs JP Participation of renal control prostaglandins in the regulation of glomerular filtration rate. Kidney Int 1981; 19: 802-809
34. Finn WE, Arendshorst WJ. The effect of prostaglandin synthetase inhibitions on renal blood flow in the rat. Am J Physiol 1976; 231: 1541
35. Tiggeler RGW, Hulme B, Wijdeveld PG. Effect of indomethacin on glomerular permeability in the nephrotic syndrome. Kidney Int 1979; 16: 312-311
36. Golbetz H, Black V, Shemesh O, Myers BD. Mechanism of the antiproteinuric effect of indomethacin in nephrotic humans. Am J Physiol 1989; 256: F44-F51
37. Oates JA, Whorton AR, Gerkens JF, Branch RA, Hollifield JW, Frolich JC. The participation of prostaglandins in the control of renin release Federation Proc 1979; 38: 72-74
38. Maack T, Park CH, Camargo MJF. Renal filtration, transport, and metabolism of protein. In: Seldin DW, Giebisch G, ed. The Kidney. Physiology and Pathophysiology Raven Press, New York, 1985;. 1773-1802
39. Gansevoort RT, de Zeeuw D, de Jong PE. Additive anti-proteinuric effect of ACE inhibition and a low-protein diet in human renal disease. Nephrol Dial Transplant 1995; 10: 497-504